Showing results (311-320 of 504) with videos related to
Sort By:
Pageof 51
Cancer|August 15, 1988
Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonusS L Cohn, H Salwen, C V Herst, et al.Blood|January 15, 1998
Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expressionW H Sun, C Pabon, Y Alsayed, et al.Anticancer Research|August 23, 2000
Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoidM M Rafi, R T Rosen, A Vassil, et al.Preventive Medicine|October 12, 2004
Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary studyMatthew J Budoff, Junichiro Takasu, Ferdinand R Flores, et al.JAMA Dermatology|February 7, 2014
High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomasJoan Guitart, Janyana Deonizio, Tara Bloom, et al.Cancer|November 1, 1987
Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancerM S Kies, S T Rosen, T K Tsang, et al.Pathology, Research and Practice|November 1, 1988
Immunohistochemical identification of exocrine and neuroendocrine subsets of large cell lung carcinomasM R Piehl, V E Gould, W H Warren, et al.Journal of Agricultural and Food Chemistry|February 7, 2002
Triterpene saponins from debittered quinoa (Chenopodium quinoa) seedsNanqun Zhu, Shuqun Sheng, Shengmin Sang, et al.Leukemia & Lymphoma|June 1, 1997
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disordersL R Kong, E Samuelson, S T Rosen, et al.Cell Cycle (Georgetown, Tex.)|December 21, 2012
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignanciesEkaterina Lesovaya, Alexander Yemelyanov, Kirill Kirsanov, et al.Pageof 51